(Q48768992)

15 February 2018

title

Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports (English)

1 reference

15 February 2018

facioscapulohumeral muscular dystrophy

main subject

0 references

5

Chinnery PF

1 reference

15 February 2018

author name string

Bushby KM

1

1 reference

15 February 2018

Pollitt C

2

1 reference

15 February 2018

Johnson MA

3

1 reference

15 February 2018

Rogers MT

4

1 reference

15 February 2018

publication date

1 December 1998

1 reference

15 February 2018

published in

Neuromuscular Disorders

1 reference

15 February 2018

volume

8

1 reference

15 February 2018

issue

8

1 reference

15 February 2018

page(s)

574-579

1 reference

15 February 2018

Genetic counselling in facioscapulohumeral muscular dystrophy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Locomotor problems in infantile facioscapulohumeral muscular dystrophy. Retrospective study of 9 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Facioscapulohumeral muscular dystrophy in early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Polymyositis with facioscapulohumeral distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Inflammatory myopathy with facioscapulohumeral distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Familial myopathies with restricted distribution, facial weakness and inflammatory changes in affected muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

"Polymyositis" with involvement of facial and distal musculature. One form of the fascioscapulohumeral syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Diagnostic criteria for facioscapulohumeral muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Unexpected sarcolemmal complement membrane attack complex deposits on nonnecrotic muscle fibers in muscular dystrophies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Familial X-linked myalgia and cramps: a nonprogressive myopathy associated with a deletion in the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

A Japanese boy with myalgia and cramps has a novel in-frame deletion of the dystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Myalgia and cramps: dystrophinopathy with wide-ranging laboratory findings

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

Steroid-responsive myalgia in a patient with Becker muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900088-1

7 January 2021

10.1016/S0960-8966(98)00088-1

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018